CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases

NCT06941129 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus
Systemic Sclerosis (SSc)
Inflammatory Myopathy
ANCA-Associated Vasculitis (AAV)
Connective Tissue Disease-Associated Thrombocytopenia
SLE-ITP

Interventions

BIOLOGICAL: UCAR T-cell

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]